Both knockdown of FAK expression and inhibition of FAK activation attenuated the effect of PRL-3 on HCC cell proliferation, adhesion and migration (Figure 5D-F; Figure S4D-F). The gene discussed is PTP4A3; the disease is hepatocellular carcinoma.